Ascelia Pharma AB (publ) logo

Ascelia Pharma AB (publ) (ACE)

Market Closed
10 Aug, 15:25
XSTO XSTO
kr
0. 57
-0.03
-4.8414%
kr
- Market Cap
- P/E Ratio
- Div Yield
878,698 Volume
- Eps
kr 0.6
Previous Close
Add Transaction
Day Range
0.56 0.6
Year Range
2.53 5.23
Want to track ACE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Ascelia Pharma AB (publ) logo
ACE Ascelia Pharma AB (publ)
14 May 2026
-
-
Ascelia Pharma AB (publ) logo
ACE Ascelia Pharma AB (publ)
5 Feb 2026
0.5
-
Ascelia Pharma AB (publ) logo
ACE Ascelia Pharma AB (publ)
5 Nov 2025
-
-
Ascelia Pharma AB (publ) logo
ACE Ascelia Pharma AB (publ)
13 Aug 2025
-
-
Ascelia Pharma AB (publ) logo
ACE Ascelia Pharma AB (publ)
14 May 2025
-
-
Ascelia Pharma AB (publ) logo
ACE Ascelia Pharma AB (publ)
7 Feb 2025
-
-
Ascelia Pharma AB (publ) logo
ACE Ascelia Pharma AB (publ)
7 Nov 2024
-
-
Ascelia Pharma AB (publ) logo
ACE Ascelia Pharma AB (publ)
15 Aug 2024
-
-
Ascelia Pharma AB (publ) logo
ACE Ascelia Pharma AB (publ)
16 May 2024
-
-
Ascelia Pharma AB (publ) logo
ACE Ascelia Pharma AB (publ)
9 Feb 2024
-
-
Ascelia Pharma AB (publ) logo
ACE Ascelia Pharma AB (publ)
2 Nov 2023
-
-

ACE Earnings Reports FAQ

What is the earnings per share (EPS) for ACE?

EPS data for ACE is currently not available, as Ascelia Pharma AB (publ) has not reported recent earnings.

What is the company's earnings growth rate?

Ascelia Pharma AB (publ) has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Ascelia Pharma AB (publ) has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Ascelia Pharma AB (publ) are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for ACE at this time, as Ascelia Pharma AB (publ) has no recent EPS data to calculate it.